Transplant

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]

EFI 2023 - Bienvenue à Nantes, France!

Immucor is excited to see you at EFI 2023 - Bienvenue à Nantes, France! As a Platinum Level sponsor, we will be sharing our latest innovations at the 36th European Immunogenetics and Histocompatibility Conference (EFI). EFI will be held live […]

PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership

NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular matching and prediction analysis, announced a multi-year partnership to expand […]

PRESS RELEASE: Immucor Announces New Innovations in Transplant Diagnostics

NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics announced two additions to its transplant diagnostics portfolio, demonstrating their ongoing commitment to new advancements in the field of histocompatibility. Immucor announced […]

MIA FORA^TM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!

Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user experience without compromising best-in-class performance and accuracy! Currently, there are multiple Next Generation Sequencing (NGS) products and software available to histocompatibility and immunogenetic laboratories. Offering […]